Table 1 Membrane-associated CD147 expression and patient demographics for PCa outcomes analysis

Pathologic stage

 pT2

143 (78.1)

0.027 (±0.010)

-

 pT3a

21 (11.5)

0.027 (±0.009)

0.77

 pT3b

19 (10.4)

0.021 (±0.007)

0.009

Gleason score

 ≤6, 3 + 4

143 (78.1)

0.028 (±0.010)

-

 4 + 3, ≥8

40 (21.9)

0.023 (±0.009)

0.02

Preoperative PSA (ng/ml)

 <4

24 (13.1)

0.026 (±0.011)

-

 4–10

125 (68.3)

0.027 (±0.010)

0.84

 >10

34 (18.6)

0.025 (±0.008)

0.87

Tumor volume

 <10 %

40 (22.1)

0.026 (±0.011)

-

 10–19 %

42 (23.2)

0.029 (±0.011)

0.82

 20–29 %

29 (16.0)

0.029 (±0.010)

0.27

 30–39 %

33 (18.2)

0.026 (±0.009)

0.77

 ≥40 %

37 (20.4)

0.024 (±0.010)

0.45

Recurrence status

 Non-recur

125 (68.3)

0.028 (±0.011)

-

 Recur

58 (31.7)

0.023 (±0.008)

0.001

Positive margins

 No

88 (48.9)

0.027 (±0.010)

-

 Yes

92 (51.1)

0.026 (±0.010)

0.53

Lymph node status

 Negative

169 (95.5)

0.027 (±0.010)

-

 Positive

8 (4.5)

0.022 (±0.009)

0.15